Bessemer Group Inc. Has $27.67 Million Position in Merit Medical Systems, Inc. $MMSI

Bessemer Group Inc. grew its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 54.2% during the fourth quarter, HoldingsChannel reports. The firm owned 313,981 shares of the medical instruments supplier’s stock after buying an additional 110,392 shares during the quarter. Bessemer Group Inc.’s holdings in Merit Medical Systems were worth $27,674,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. Tudor Investment Corp ET AL acquired a new stake in shares of Merit Medical Systems in the 3rd quarter valued at approximately $2,913,050,000. State Street Corp boosted its stake in shares of Merit Medical Systems by 1.1% in the 2nd quarter. State Street Corp now owns 2,218,432 shares of the medical instruments supplier’s stock valued at $207,379,000 after purchasing an additional 24,569 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Merit Medical Systems by 377.7% in the 3rd quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock valued at $103,248,000 after purchasing an additional 980,823 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Merit Medical Systems by 6.2% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,177,862 shares of the medical instruments supplier’s stock valued at $98,021,000 after purchasing an additional 68,711 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Merit Medical Systems by 7.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 917,122 shares of the medical instruments supplier’s stock valued at $76,332,000 after purchasing an additional 64,920 shares in the last quarter. 99.66% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Barrington Research reduced their price target on shares of Merit Medical Systems from $109.00 to $107.00 and set an “outperform” rating on the stock in a research note on Monday, April 20th. Wall Street Zen downgraded shares of Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 5th. Needham & Company LLC reduced their price target on shares of Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating on the stock in a research note on Friday, May 1st. Weiss Ratings downgraded shares of Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Friday, May 8th. Finally, Piper Sandler cut their target price on shares of Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating on the stock in a research report on Friday, April 17th. Eight investment analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $92.80.

Insider Activity at Merit Medical Systems

In other news, Director Lynne N. Ward sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total value of $313,050.00. Following the transaction, the director owned 7,809 shares in the company, valued at approximately $488,921.49. The trade was a 39.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brian G. Lloyd purchased 2,000 shares of the company’s stock in a transaction dated Thursday, May 7th. The stock was purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the transaction, the insider directly owned 2,000 shares in the company, valued at approximately $125,240. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.

Merit Medical Systems Stock Down 1.9%

NASDAQ:MMSI opened at $61.36 on Friday. The firm’s 50 day simple moving average is $67.63 and its 200 day simple moving average is $78.47. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.08 and a quick ratio of 3.46. Merit Medical Systems, Inc. has a one year low of $59.74 and a one year high of $100.05. The company has a market cap of $3.66 billion, a PE ratio of 26.56, a P/E/G ratio of 1.91 and a beta of 0.58.

Merit Medical Systems (NASDAQ:MMSI) last posted its earnings results on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping the consensus estimate of $0.84 by $0.10. Merit Medical Systems had a net margin of 9.03% and a return on equity of 13.54%. The business had revenue of $381.88 million for the quarter, compared to the consensus estimate of $377.59 million. During the same period last year, the company earned $0.86 EPS. The firm’s revenue was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, research analysts anticipate that Merit Medical Systems, Inc. will post 3.61 earnings per share for the current year.

Merit Medical Systems Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.